Should you let Wegovy warm up before injecting?

Cold injection, more discomfort: refrigerated semaglutide solution is denser and slightly more viscous; injecting it straight from the fridge is associated with more stinging than the same dose at room temperature.
30 minutes is the guidance: the product information recommends leaving the pen out of the fridge for at least 30 minutes before use, but no longer than the time window stated in the leaflet.
Do not apply heat: warming the pen under hot water, on a radiator, or in direct sunlight is not recommended — the storage section of the SmPC is clear that only passive room-temperature warming is safe.
Room temperature has a time limit: Wegovy can be kept out of the refrigerator for a set period (stated in your patient information leaflet); beyond that window it should be discarded rather than returned to the fridge and reused.

The short answer is yes. The Wegovy SmPC and patient information leaflet both advise removing the pen from the refrigerator and allowing it to reach room temperature for 30 minutes before you inject. Injecting a cold solution is not dangerous, but it does increase the chance of stinging and discomfort at the site. That practical detail is confirmed in Mounjaro and Wegovy's product information on the eMC, and the principle underpins NHS guidance on injectable weight-loss medicines more broadly. Semaglutide (Wegovy) is a prescription-only medicine requiring clinical assessment before a prescriber decides whether it is suitable for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the 30-minute warm-up works in practice — and what the guidance actually says

What the product guidance says about temperature and injection comfort

The Wegovy patient information leaflet, published on the electronic Medicines Compendium (eMC), is the authoritative source here. It states that the pen should be taken from the fridge and left at room temperature for at least 30 minutes before injecting. That instruction exists for one straightforward reason: a solution at 2–8°C is cooler than the subcutaneous tissue it enters, and that temperature difference is what causes the sharp sting some people notice when they inject without waiting.

It is worth knowing what the guidance does not say. It does not say the pen is unsafe to inject cold, the medicine remains pharmacologically unchanged. The recommendation is purely about comfort and tolerability, which matters because stinging at the injection site can make people hesitant about their next dose. Consistency of dosing is central to how semaglutide works over weeks and months, so anything that removes a barrier to injection day is worth taking seriously.

Some people find that setting a 30-minute reminder at the same time each week builds the habit naturally, and our page on how long to leave Wegovy out before injecting walks through the timing in more detail, including what to do if your routine gets disrupted. A consistent routine also reduces the chance of forgetting the warm-up entirely.

The time limit on leaving Wegovy out of the fridge

The warm-up window is not open-ended. Your patient information leaflet specifies the maximum time Wegovy can remain unrefrigerated before it must be discarded. The precise figure is medicine-specific and can vary between formulations, which is why this page does not quote a single number: check your own leaflet, or ask the prescriber or pharmacist who looks after your treatment.

What the guidance does make clear is that once the pen has been out of the fridge beyond that permitted window, it should not be returned to the refrigerator and used at a later date. If you have let yours sit out too long, discard it in a sharps container and contact your prescriber about a replacement before your next scheduled dose.

One common misreading of the guidance is the idea that a longer warm-up is better. Thirty minutes is sufficient; leaving the pen out for several hours or overnight is not recommended and may compromise the medicine.

Where you inject also affects comfort, and should be paired with the warm-up

Temperature is one factor in injection comfort; site preparation is another. NHS guidance on semaglutide notes that the three licensed sites are the abdomen, the thigh, and the upper arm. Rotating between sites each week helps avoid localised skin thickening (lipohypertrophy), which can affect how the medicine is absorbed.

Technique details (such as whether to pinch the skin, the angle of insertion, and how long to hold the pen in place) are covered in the step-by-step guide to how to inject Wegovy. If you are considering the upper arm, you may also want to read the specific guidance on injecting Wegovy in the arm, since self-injection there requires a slightly different approach.

Wiping the site with an alcohol swab beforehand is standard practice; medical-grade alcohol swabs are the appropriate choice rather than household wipes.

How this fits into your injection routine as a whole

The warm-up question does not sit in isolation. When you inject during the week, what you eat beforehand, and how you time the dose relative to any other oral medicines all interact with how well you tolerate the treatment. Our page on when to inject Wegovy covers the timing question in detail, and there is a separate guide on whether to eat before your injection that is worth reading alongside this one.

On pricing and what a private Wegovy prescription includes in the UK, the cost of Wegovy page sets out the honest picture, including what headline prices sometimes leave out.

Wegovy is a prescription-only medicine. A clinician needs to assess your full health picture before prescribing, factors including your current BMI, any comorbidities, other medicines you take, and your medical history all feed into that decision. If you are not yet on treatment and want to understand whether you might be suitable, our prescribers are the right place to start. Speak to our prescribers through a free consultation reviewed by a GPhC-registered Independent Prescriber, with no algorithm involved.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions